NLM AIDSLINE
Intellectual property issues in a clinical trial: a corporate
perspective.
Fersko RS; Connolly MJ; Tanner Propp & Fersko, New York, New York 10016.
July 30, 1994
Qual Assur. 1992 Jun;1(3):237-48. Unique Identifier : AIDSLINE
Acquired Immunodeficiency Syndrome/*THERAPY *Clinical
Trials/LEGISLATION & JURISPRUD Confidentiality/LEGISLATION & JURISPRUD
Conflict of Interest/LEGISLATION & JURISPRUD Drug
Industry/*ORGANIZATION & ADMIN Financing, Government/LEGISLATION &
JURISPRUD Health Policy/LEGISLATION & JURISPRUD Human
*Interinstitutional Relations National Institutes of Health
(U.S.)/*ORGANIZATION & ADMIN *Patents/LEGISLATION & JURISPRUD Research
Support/LEGISLATION & JURISPRUD United States JOURNAL ARTICLE
www.aegis.org